Chlamydia pneumoniae pneumonia: An evolving clinical spectrum
D Megran1, R W Peeling, T J Marrie
1Department of Medicine, University of Calgary, Calgary, Alberta; National Laboratory for Sexually Transmitted Diseases, Laboratory Centre for Disease Control, Winnipeg, Manitoba; and Departments of Medicine and Microbiology, Dalhousie University and the Victoria General Hospital, Halifax, Nova Scotia.
Chlamydia pneumoniae pneumonia is a significant cause of community-acquired pneumonia, accounting for 6-10% of hospital admissions. This study highlights its varied severity and potential extrapulmonary effects.
Area of Science:
- Medicine
- Infectious Diseases
- Respiratory Medicine
Background:
- Chlamydia pneumoniae is an emerging pathogen in respiratory infections.
- It is a notable cause of community-acquired pneumonia (CAP).
Observation:
- This pathogen accounts for 6-10% of CAP cases requiring hospitalization.
- Two patient cases illustrate the clinical spectrum of C. pneumoniae pneumonia.
Findings:
- The severity of C. pneumoniae pneumonia can range widely.
- Extrapulmonary manifestations associated with C. pneumoniae infection are observed.
Implications:
- Understanding the clinical presentation of C. pneumoniae is crucial for diagnosis and management.
- Further research into extrapulmonary complications may be warranted.
Related Concept Videos
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Bacterial Phylum Chlamydiae
Pneumonia III: Complications and Assessment

